PAREXEL INTERNATIONAL CORP
(NASDAQ: PRXL)

PAREXEL International Corporation (PAREXEL is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company�s product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance, regulatory and product development and commercialization among others. In July 2014, PAREXEL International Corp acquired ATLAS Medical Services.

3.800 s

-0.120 (-3.06%)
Range - - -   (-%)
Open -
Previous Close 3.920
Bid Price 3.800
Bid Volume -
Ask Price 3.810
Ask Volume -
Volume -
Value -
Remark s
Delayed prices. Updated at 03 Aug 2021 12:29.
Data powered by
View All Events

About PAREXEL INTERNATIONAL CORP

PAREXEL International Corporation (PAREXEL is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. ...
more

Share your investing ideas
Please login to view stock data and analysis